Dash Bio

Dash Bio

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://dash.bio

Last Round

Series A

Jul 23, 2025

Est. Valuation

$17.5M

Total Funding Raised

$6.5M

Company Overview

Dash Bio is a biotechnology company that provides an automated bioanalysis platform using AI and robotics to accelerate clinical drug development for pharmaceutical and biotech companies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Workflow Automation, Medical AI, Industrial Robotics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

clinical bioanalysiscontract research organizationCROautomated bioanalysislab automationcloud labdrug developmentclinical trialsrobotic cloud labGLP compliantassay servicesLC-MSELISA assayscustom assay developmentqPCRddPCRpreclinical studiesAI for bioanalysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dash Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Dash Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJul 23, 2025
SeedOct 24, 2024

Key People

Founding team and executive leadership

Ander Tallett

Co-Founder COO

Founding Team

Dave Johnson

Co-founder CEO

Founding Team

Dash Bio Investors

Notable investors and investment history

InvestorRounds
CybernetixSeries A
LifeX GlobalSeries A
LifeX VenturesSeed, Series A
The Aligned FundSeries A
Freestyle VenturesSeries A, Seed
Swift VenturesSeed, Series A
Swift VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 3, 2026

    Opened a new 24,000 sq ft GLP-compliant facility in Massachusetts.

  • Jul 23, 2025

    $11M round with $6.5M pre-money valuation.

Dash Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Dash Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Dash Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range24
Year Founded2024
Last FundingJul 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.